Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/8341644

Proc. Natl. Acad. Sci. U.S.A. 1993 Jul 15 90 14 6395-9

Download in:

View as

Triples

General Info

PMID
8341644